Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment.
Miciaccia M, Rizzo F, Centonze A, Cavallaro G, Contino M, Armenise D, Baldelli OM, Solidoro R, Ferorelli S, Scarcia P, Agrimi G, Zingales V, Cimetta E, Ronsisvalle S, Sipala FM, Polosa PL, Fortuna CG, Perrone MG, Scilimati A. Miciaccia M, et al. Pharmaceuticals (Basel). 2024 Jan 19;17(1):135. doi: 10.3390/ph17010135. Pharmaceuticals (Basel). 2024. PMID: 38276008 Free PMC article.
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior.
Solidoro R, Miciaccia M, Bonaccorso C, Fortuna CG, Armenise D, Centonze A, Ferorelli S, Vitale P, Rodrigues P, Guimarães R, de Oliveira A, da Paz M, Rangel L, Sathler PC, Altomare A, Perrone MG, Scilimati A. Solidoro R, et al. Among authors: miciaccia m. Eur J Med Chem. 2024 Feb 15;266:116135. doi: 10.1016/j.ejmech.2024.116135. Epub 2024 Jan 10. Eur J Med Chem. 2024. PMID: 38219659
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines.
Schirizzi A, Contino M, Carrieri L, Riganti C, De Leonardis G, Scavo MP, Perrone MG, Miciaccia M, Kopecka J, Refolo MG, Lotesoriere C, Depalo N, Rizzi F, Giannelli G, Messa C, D'Alessandro R. Schirizzi A, et al. Among authors: miciaccia m. Front Oncol. 2023 Feb 16;13:1129832. doi: 10.3389/fonc.2023.1129832. eCollection 2023. Front Oncol. 2023. PMID: 36874116 Free PMC article.
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes.
Perrone MG, Vitale P, Miciaccia M, Ferorelli S, Centonze A, Solidoro R, Munzone C, Bonaccorso C, Fortuna CG, Kleinmanns K, Bjørge L, Scilimati A. Perrone MG, et al. Among authors: miciaccia m. Pharmaceuticals (Basel). 2022 May 26;15(6):668. doi: 10.3390/ph15060668. Pharmaceuticals (Basel). 2022. PMID: 35745587 Free PMC article.
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design.
Friedrich L, Cingolani G, Ko YH, Iaselli M, Miciaccia M, Perrone MG, Neukirch K, Bobinger V, Merk D, Hofstetter RK, Werz O, Koeberle A, Scilimati A, Schneider G. Friedrich L, et al. Among authors: miciaccia m. Adv Sci (Weinh). 2021 Aug;8(16):e2100832. doi: 10.1002/advs.202100832. Epub 2021 Jun 27. Adv Sci (Weinh). 2021. PMID: 34176236 Free PMC article.
15 results